Register entry
Orion Corporation, Orion Pharma
- Registered sites
- 3
- Drug products
- 3
- Live patents
- 0
- Countries
- 1
- Base
- Finland
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackaging
Sites
Facilities
3| Site | Location | Operations | FEI |
|---|---|---|---|
| Orion Corporation, Orion Pharma | EspooFinland | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3003073605 |
| Orion Corporation, Orion Pharma | SaloFinland | Labelling, Packaging | 3010642517 |
| Orion Corporation, Orion Pharma | TurkuFinland | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3003743938 |
Catalogue
Marketed products
3Showing 3 of 3.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | darolutamide | TABLET | DRUG FOR FURTHER PROCESSING |
| - | entacapone | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | toremifene citrate | TABLET | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.